EARLY BIRD RATE ENDS TODAY! |
|
|
The Fierce Pharma PR & Communications Summit in Jersey City, NJ on July 18-19, 2023 is the premier event for life sciences communicators, offering attendees ample opportunities for education, collaboration and networking. Hear from some of the most experienced and innovative minds in Pharma and Biotech communications from organizations like AbbVie, Moderna, bluebird bio, GSK, Regeneron, Gilead, AstraZeneca and more. You're sure to walk away with actionable strategies and useful tools to bring back to your organization and take your communications strategy to the next level. See below for sessions we think you'd not only enjoy, but will find extremely beneficial for your career at Takeda. VIEW THE AGENDA>> The deadline for the Early Bird Rate is May 30th and limited passes are left at that rate. Don't wait to secure your spot and register now. |
|
|
I look forward to seeing you in July! Best regards, Michelle Benz Conference Production Director Fierce Life Sciences |
|
|
SESSIONS FIT FOR YOUR NEEDS: Navigating the Intersection of Social Issues and Brand Reputation in the Pharmaceutical Industry - Roslyn L. Patterson, Access to Healthcare Enthusiast and Strategic Advisor, Lord & Golden
- Aleisia Gibson Wright, Managing Director, Healthcare, Lippe Taylor
- Ed Harnaga, SVP, Global Head of Communications & Enterprise Reputation, Pfizer
- Allyson Funk, Head of U.S. Communications and Public Affairs, UCB
- Geoff Curtis, EVP, Corporate Affairs and Chief Communications Officer, Horizon Therapeutics
- Alex Kalomparis, SVP Public Affairs, Gilead Sciences
Weathering the Biotech Storm: Effective Communication and Maintaining Strong Investor Appeal - Victoria Fort, VP, Corporate Affairs, Frontier Medicines
- Neda Safarzadeh, VP, Head of: Investor Relations/Public Relations/Marketing, Arcturus Therapeutics
- Priyanka Shah, VP, Investor Relations and Communications, Kinnate Biopharma
- Lisa McCormick Lavery, VP, Communications and Investor Relations, Eikon Therapeutics
- Sarah Spencer, VP, Head of Corporate Communications, Vor Biopharma
Case Study: Getting More Diverse Candidates into the Top of the Funnel - Carrie Fernandez, VP and Head of Communications, Global Oncology, Takeda
- Elyse Margolis, President, Integrated Client Solutions, Real Chemistry
- Alejandra Elliot, Account Associate, Real Chemistry
Driving Change through Effective Communication: Pharma's Responsibility in the Drug Pricing Discussion - Nick Shipley, Chief Advocacy Officer, Biotechnology Innovation Organization (BIO)
- Deirdre Parsons, Senior Director, Global Public Policy & Government Relations, Alnylam Pharmaceuticals
- Anne Winter, Senior Managing Director, FTI Consulting
- Paul King, VP, Market Access Marketing, Urovant Sciences
- Karin Hoelzer, DVM, PhD, Director, Policy and Regulatory Affairs, National Organization for Rare Disorders (NORD)
|
|
|
Inquire About Group Discounts |
|
|
Maximize learning by attending as a group and save up to 25% |
| |
|
Apply to the Rising Stars Program for a Complimentary Pass! PR and communications professionals who are actively employed at a Pharma or Biotech company and have less than 5 years experience can apply for a complimentary pass. All applications submitted are subject to review. Please visit our website for more details. |
|
|
THANK YOU TO OUR 2023 PARTNERS! |
|
|
If you no longer wish to receive promotion on this event, simply unsubscribe. Refer to our Privacy Policy. Fierce Life Sciences is a division of Questex LLC. 685 3rd Ave 21st Floor New York, NY 10017
Contact us © 2023 Questex LLC. All Rights Reserved. Reproduction in whole or in part is prohibited without written permission. |
|
|
|